reglab/statecodes huggingface dataset:
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-22 - Maintenance of apparatus

Current through July 10, 2024
All rooms, chambers, containers autoclaves, tanks, boilers,
				ducts, valves, gauges, heaters and all auxiliary equipment necessary or
				incidental for the proper sterilization of articles, filling materials or metal
				shall be clean and maintained at all times in good repair and in proper working
				condition.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-23 - Fumigation: Germicides

Current through July 10, 2024
(a) Formaldehyde is
			 in common use and is accepted as a germicide (not an insecticide). The
			 commissioner shall permit the use of a proper formaldehyde process until
			 further notice, provided this process is used in conjunction with an approved
			 insecticide process. (See section
			 21a-235-20.)
(b) When approved by the commissioner,
			 formaldehyde gas in the presence of moisture may be used for treating either
			 loose materials or complete articles when the filling is not compressed to a
			 degree in excess of the usual compression of cotton felt. Articles shall be so
			 spaced as to allow free circulation of gas. The exhaust from the sterilizing
			 room or cabinet shall be carried by a duct or a chimney flue extending above
			 the roof of the building.
(c)
			 Formaldehyde gas generated from one pint of formaldehyde solution (United
			 States Pharmacopoeia standard) for each one thousand cubic feet of space in the
			 sterilizing chamber is acceptable. Materials shall be treated with formaldehyde
			 gas and moisture for at least ten hours. The minimum quantity of solution
			 permitted is two ounces, regardless of how small the sterilizing chamber is.
			 The solution shall be heated or boiled to release the gas. The safest and most
			 convenient way to do this is to add to the solution one-half its weight of
			 potassium permanganate. This boils the solution and releases the gas. To avoid
			 boiling over, the mixing should be done in a large pail. The gas shall be
			 disseminated throughout the chamber so as to reach all parts of the materials
			 treated. Sufficient moisture in the chamber may be produced by thoroughly
			 sprinkling the floor of the chamber with warm water before commencing to
			 sterilize. The room shall be gas tight and equipped with air inlet and outlet.
			 (An exhaust fan will greatly facilitate the removal of dead gases and fumes
			 after sterilization is completed.) Tight closure gates or valves shall be
			 provided for both inlet and outlet. Shelves shall be of lattice construction.
			 This process is not suitable, and shall not be approved, for complete
			 sterilization of any materials or articles. For complete sterilization, an
			 approved insecticide shall be used in addition to formaldehyde.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-25 - Application of insecticides and germicides

Current through July 10, 2024
Approved insecticides and germicides may be applied in either
				of two ways: (1) They may be applied in the form of a gas generated in a
				properly constructed gas tight vault or chamber; or (2) they may be applied
				with an approved spraying device.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-26 - Temperature of germicides and insecticides

Current through July 10, 2024
Any chemical germicide or insecticide acts more quickly and
				effectively at high temperatures. A temperature range from 75°F. to
				110°F. is desirable. In no case shall the temperature be allowed to fall
				below 70°F.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-28 - Formaldehyde gas

Current through July 10, 2024
If formaldehyde is applied in gaseous form, the full strength
				standard U.S. Pharmacopoeia solution shall be used undiluted. The formaldehyde
				gas is generated by boiling this solution. The most satisfactory way of
				generating the formaldehyde gas is to add one-half its weight of potassium
				permanganate.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-29 - Poisonous gas

Current through July 10, 2024
Those who desire to use hydrocyanic gas or any other poisonous
				gas as an insecticide shall secure the approval of the local health officers
				before installing the chamber or vault for the use of such
				processes.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-30 - Spraying

Current through July 10, 2024
(a) Certain insecticides may be applied by
			 direct spray or mist spray methods. When these insecticides are effective, they
			 may be approved and used. The germicides and insecticides listed in these
			 specifications are intended merely to indicate the properties and types of
			 chemicals and processes requisite for proper sterilization. The list is not
			 intended to be complete. Any germicide or insecticide not on the list which
			 shall be shown to destroy germs or insects effectively under reasonable
			 conditions without involving any serious hazards will be approved by the
			 commissioner and added to the list.
(b) Two methods of applying chemical
			 germicides and insecticides by means of a spray are permissible:
(1) Direct spraying. The material or article
			 shall be placed in a separate, closed room or chamber which shall be quite
			 tight, but need not be gas tight. Either a good hand sprayer or a power sprayer
			 may be used to spray the chemicals on the materials or articles. The materials
			 or articles shall be thoroughly wetted with the chemical solution on all
			 surfaces. The amount of chemicals used shall be approximately the same as would
			 be required in the fumigation process for the same materials or articles;
(2) The mist spray method. A
			 gas-tight chamber shall be used. The chemicals are released from container
			 tanks and are sprayed into the sterilizing chamber by an atomizer spray in the
			 form of a mist. The amount of chemicals used shall be the same as that required
			 for the same articles to be sterilized by fumigation.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-31 - Formaldehyde spray

Current through July 10, 2024
(a) If formaldehyde
			 is applied with a spray, the standard U.S. Pharmacopoeia solution shall be
			 diluted with three parts of water to one part of solution. This gives a ten per
			 cent formaldehyde solution which is sufficient to kill all active germs which
			 come in contact with the solution. (This ten per cent solution will not injure
			 or fade fabrics.)
(b) If
			 formaldehyde solution is applied with a spray, the operator shall wear rubber
			 gloves and a mask to protect hands and eyes against the irritating effects of
			 this solution.
Connecticut Administrative Code › Title 21a - Consumer Protection › 235 - Bedding and Upholstered Furniture › Section 21a-235-32 - 'Off sale' articles

Current through July 10, 2024
The commissioner or a representative of the commissioner may
				order "off sale" and so tag any article of bedding, upholstered furniture or
				material therefor not tagged or labeled as required by these regulations or
				which in any other respect does not conform with the requirements of statute or
				regulation issued under the authority thereof, and may take such other action
				as may be authorized by statute. No article or material so ordered "off sale"
				shall be sold or used, nor shall such materials or articles or contents thereof
				be altered or removed in whole or part, until such articles or materials are
				released by the commissioner or his authorized representative and the "off
				sale" tag removed. All articles or materials ordered "off sale" are subject to
				frequent examination and shall be so placed as to be readily accessible at all
				times for examination upon demand of the commissioner or his authorized
				representative.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Section 21a-243-1 - Volatile substances

Current through July 10, 2024
(a) The following
			 volatile substances are hereby designated as controlled drugs to the extent
			 that said chemical substances or compounds containing said chemical substances
			 are sold, prescribed, dispensed, compounded, possessed or controlled or
			 delivered or administered to another person, with the purpose that said
			 chemical substances shall be breathed, inhaled, sniffed or drunk to induce a
			 stimulant, depressant or hallucinogenic effect upon the higher functions of the
			 central nervous system: Acetone; toluol; trichloroethylene; isopropanol;
			 methanol; ether; methyl cellosolve acetate; toluene; hexane; butyl alcohol;
			 benzene; methyl ethyl ketone; cyclohexanone; pentochlorophenol; ethyl acetate;
			 methyl isobutyl ketone; trichloroethane, and dichlorodifluoromethane.
(b) Insofar as it is the express intent of
			 these regulations to provide medical treatment whenever possible, there is
			 hereby created the presumption that one who is found to have inhaled or to be
			 under the influence of the above-described volatile substances shall be deemed
			 to be psychologically dependent upon said volatile substances.
(c) To the extent that it is possible,
			 medical treatment rather than criminal sanctions shall be afforded individuals
			 who breathe, inhale, sniff or drink the above-named volatile
			 substances.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Section 21a-243-2 - Criminal liability of vendor

Current through July 10, 2024
No vendor of the aforementioned volatile substances shall be
				deemed to have violated the provisions of chapter 420b of the general statutes
				insofar as sale, dispensing or delivering of one or more of said volatile
				substances or compounds containing said chemical substances is concerned,
				unless he knew or should have known of the improper purpose to which said
				substance was to be put.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Section 21a-243-3 - When volatile substances not controlled drug

Current through July 10, 2024
The above drugs are designated as controlled drugs only for the
				limited purpose stated in section
				21a-243-1.
				Insofar as substances containing said drugs are possessed, sold, dispensed,
				compounded or delivered for licit purposes, i.e., other than to produce a
				stimulant, depressant or hallucinogenic effect upon the higher functions of the
				central nervous system by breathing, inhaling, sniffing or drinking, such
				substances are expressly not controlled and neither the regulatory provisions,
				including but not limited to record keeping, licensing, and the writing of
				prescriptions nor the criminal sanctions and proscriptions of chapter 420b of
				the general statutes shall apply.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Section 21a-243-4 - Anesthesia

Current through July 10, 2024
The breathing, inhalation, sniffing or drinking of anesthesia
				for medical or dental purposes under the direction of a physician, dentist or
				osteopath acting in the course of his professional practice, is determined to
				be a licit purpose and not in contravention of these regulations or the
				provisions of chapter 420b of the general statutes.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Section 21a-243-5 - Controlled drugs

Current through July 10, 2024
The following substances are hereby designated as controlled
				drugs for all purposes of chapter 420b of the general statutes: Datura
				stramonium, hyoscyamus niger, atropa belladonna or the alkaloids atropine,
				hyoscyamine, belladonnine, apoatropine, or any mixture of these alkaloids such
				as daturine, or the synthetic homatropine or any salts of these alkaloids. Any
				drug or preparation containing any of the above-mentioned substances which is
				permitted by federal food and drug laws to be sold or dispensed without a
				prescription or written order shall not be a controlled drug.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Schedules of Controlled Substances › Section 21a-243-7 - Controlled substances in schedule I

Current through July 10, 2024
The controlled substances listed in this regulation are included
				  by whatever official, common, usual, chemical, or trade name designation in schedule
				  I:
(a) Any of the following opiates,
				including their isomers, esters, ethers, salts and salts of isomers, esters and
				ethers, unless specifically excepted, whenever the existence of these isomers,
				esters, ethers and salts is possible within the specific chemical designation:
(1) Acetylalpha-methylfentanyl;
(2) Acetylmethadol;
(3) Allylprodine;
(4) Alphacetylmethadol (except
				Levo-alphacetylmethadol or LAAM);
(5)
				Alphameprodine;
(6)
				Alphamethadol;
(7)
				Alpha-methylfentanyl;
(8)
				Alphamethylthiofentanyl;
(9)
				Benzethidine;
(10)
				Betacetylmethadol;
(11)
				Beta-hydroxy-fentanyl;
(12)
				Beta-hydroxy-3-methylfentanyl;
(13)
				Betameprodine;
(14)
				Betamethadol;
(15)
				Betaprodine;
(16) Clonitazene;
(17) Dextromoramide;
(18) Diampromide;
(19) Diethylthiambutene;
(20) Difenoxin;
(21) Dimenoxadol;
(22) Dimepheptanol;
(23) Dimethylthiambutene;
(24) Dioxaphetyl Butyrate;
(25) Dipipanone;
(26) Ethylmethylthiambutene;
(27) Etonitazene;
(28) Etoxeridine;
(29) Furethidine;
(30) Hydroxypethidine;
(31) Ketobemidone;
(32) Levomoramide;
(33) Levophenacylmorphan;
(34) 3-methylfentanyl;
(35) 3-methylthiofentanyl;
(36) Morpheridine;
(37) Noracymethadol;
(38) Norlevorphanol;
(39) Normethadone;
(40) Norpipanone;
(41) Para-fluorofentanyl;
(42) PEPAP
				(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
(43) Phenadoxone;
(44) Phenampromide;
(45) Phenomorphan;
(46) Phenoperidine;
(47) Piritramide;
(48) Proheptazine;
(49) Properidine;
(50) Propiram;
(51) Racemoramide;
(52) Thiofentanyl;
(53) Tilidine;
(54) Trimeperidine.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Schedules of Controlled Substances › Section 21a-243-8 - Controlled substances in schedule II

Current through July 10, 2024
The controlled substances listed in this regulation are included
				  by whatever official, common, usual, chemical, or trade name designation in schedule
				  II:
(a) Any of the following substances,
				except those narcotic drugs listed in other schedules, whether produced directly or
				indirectly by extraction from substances of vegetable origin, or independently by
				means of chemical synthesis, or by combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound,
				derivative, or preparation of opium or opiate excluding Apomorphine, Dextrorphan,
				Nalbuphine, Naloxone, Nal-trexone, and their salts, but including the following: Raw
				opium, opium extracts, opium fluid extracts, powdered opium, granulated opium,
				tincture of opium, codeine, dihydroetorphine, ethylmorphine, etorphine
				hydrochloride, hydrocodone, hydromorhone, metopon, morphine, oripavine, oxycodone,
				oxymorphone and thebaine;
(2) Any salt,
				compound,isomer, derivative or preparation thereof which is chemically equivalent or
				identical with any of the substances referred to in paragraph (1), but not including
				the isoquinoline alkaloids of opium;
(3)
				Opium poppy and poppy straw;
(4) Coca
				leaves and any salt, compound, derivative, or preparation of coca leaves, and any
				salt, compound, derivative, or preparation thereof which is chemically equivalent or
				identical with any of these substances, but not including decocainized coca leaves
				or extractions which do not contain cocaine or ecgonine;
(5) Concentrate of poppy straw (the crude extract
				of poppy straw in either liquid, solid or powder form which contains the
				phenanthrine alkaloids of opium poppy).
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Schedules of Controlled Substances › Section 21a-243-9 - Controlled substances in schedule III

Current through July 10, 2024
The controlled substances listed in this regulation are included
				  by whatever official, common, usual, chemical, or trade name designation in schedule
				  III:
(a) Unless specifically excepted or
				unless listed in another schedule, any material, compound, mixture, or preparation
				which contains any quantity of the following substances having a stimulant effect on
				the central nervous system, including its salts, isomers, and salts of such isomers
				whenever the existence of such salts, isomers, and salts of isomers is possible
				within the specific chemical designation:
(1)
				Benzphetamine;
(2)
				Chlorphentermine;
(3)
				Clortermine;
(4)
				Phendimetrazine.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Schedules of Controlled Substances › Section 21a-243-10 - Controlled substances in schedule IV

Current through July 10, 2024
The controlled substances listed in this regulation are included
				  by whatever official, common, usual, chemical, or trade name designation in schedule
				  IV:
(a) Any material, compound, mixture or
				preparation which contains any quantity of the following substances having a
				potential for abuse associated with a depressant effect on the central nervous
				system:
(1) Alprazolam;
(2) Barbital;
(3) Bromazepam;
(4) Camazepam;
(5) Carisoprodol;
(6) Chloral betaine;
(7) Chloral hydrate;
(8) Chlordiazepoxide;
(9) Clobazam;
(10) Clonazepam;
(11) Clorazepate;
(12) Clotiazepam;
(13) Cloxazolam;
(14) Delorazepam;
(15) Diazepam;
(16) Dochloralphenazone;
(17) Estazolam;
(18) Etholorvynol;
(19) Ethinamate;
(20) Ethyl-lofiazepate;
(21) Fludiazepam;
(22) Flunitrazepam;
(23) Flurazepam;
(24) Halazepam;
(25) Haloxazolam;
(26) Ketazolam;
(27) Loprazolam;
(28) Lorazepam;
(29) Lormetazepam;
(30) Mebutamate;
(31) Medazepam;
(32) Meprobamate;
(33) Methohexital;
(34) Methylphenobarbital
				(mephobarbital);
(35)
				Midazolam;
(36) Nimetazepam;
(37) Nitrazepam;
(38) Nordiazepam;
(39) Oxazepam;
(40) Oxazolam;
(41) Paraldehyde;
(42) Petrichloral;
(43) Phenobarbital;
(44) Pinazepam;
(45) Prazepam;
(46) Quazepam;
(47) Temazepam;
(48) Tetrazepam;
(49) Triazolam;
(50) Zaleplon;
(51) Zolpidem;
(52) Zopiclone.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Schedules of Controlled Substances › Section 21a-243-11 - Controlled substances in schedule V

Current through July 10, 2024
The controlled substances listed in this regulation are included
				  by whatever official, common, usual, chemical, or trade name designation in schedule
				  V:
(a) Any compound, mixture, or
				preparation containing limited quantities of any of the following controlled drugs,
				which also contain one or more noncontrolled active medicinal ingredients in
				sufficient proportion to confer upon the compound, mixture, or preparation, valuable
				medicinal qualities other than those possessed by the controlled drug alone:
(1) Not more than 200 milligrams of codeine, or
				any of its salts, per 100 milliliters or per 100 grams;
(2) Not more than 100 milligrams of
				dihydrocodeine, or any of its salts, per 100 milliliters or per 100 grams;
(3) Not more than 100 milligrams of ethylmorphine,
				or any of its salts, per 100 milliliters or per 100 grams;
(4) Not more than 2.5 milligrams of diphenoxylate
				and not less than 25 micrograms of atropine sulfate per dosage unit;
(5) Not more than 100 milligrams of opium per 100
				milliliters or per 100 grams;
(6) Not
				more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine
				sulfate per dosage unit.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Drug Prescriptions Transmitted by Facsimile Machines › Section 21a-243-12 - Definitions

Current through July 10, 2024
For the purpose of Sections 21a-243-12 through
				  21a-243-17
				  of the Regulations of Connecticut State Agencies, the following terms shall
				  have the meanings indicated:
(a)
				"Controlled substance" has the meaning given to this term by Connecticut
				General Statutes, Section
				21a-240(9);
(b) "Facsimile machine" means a machine that
				electronically transmits facsimiles through connection with a telephone
				network;
(c) "Prescribing
				Practitioner" means any person licensed by the state of Connecticut, any other
				state, the District of Columbia or the Commonwealth of Puerto Rico and
				authorized to prescribe controlled substances within the scope of his or her
				practice; and
(d) "Long Term Care
				Facility" means a facility or institution as defined by the federal government
				in
				21 CFR
				1300.01.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Drug Prescriptions Transmitted by Facsimile Machines › Section 21a-243-13 - Dispensing of prescriptions transmitted by means of a facsimile machine

Current through July 10, 2024
No pharmacist or pharmacy may dispense controlled substances
				  upon a prescription transmitted by means of a facsimile machine unless such
				  prescription fully complies with Sections
				  21a-243-14
				  through
				  21a-243-18,
				  inclusive, of the Regulations of Connecticut State Agencies.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Drug Prescriptions Transmitted by Facsimile Machines › Section 21a-243-14 - Schedule II controlled substances

Current through July 10, 2024
(a) Prescriptions
				for Schedule II controlled substances may be transmitted by a prescribing
				practitioner or his agent to a pharmacy by means of a facsimile machine
				provided the original written, signed prescription is provided to the
				pharmacist for review prior to the actual dispensing of the controlled
				substance, except as provided for in subsections (b) and (c) of this section.
				The original written prescription, once received by the pharmacist, shall be
				reviewed to ensure that it conforms with the requirements of section
				21a-249
				of the Connecticut General Statutes and shall be maintained as the original
				record of dispensing. The facsimile prescription order shall not be considered
				to be the actual prescription, but only a record of the transmission of the
				prescription order.
(b)
				Prescriptions for Schedule II narcotic substances to be compounded for direct
				administration to a patient by parenteral, intravenous, intramuscular,
				subcutaneous or intraspinal infusion may be transmitted by the prescribing
				practitioner or his agent to a pharmacy by facsimile. The prescription
				transmitted via facsimile will be accepted as the original prescription for
				purposes of this section.
(c)
				Prescriptions for Schedule II controlled substances for patients of a long term
				care facility may be transmitted by a prescribing practitioner or his agent to
				the dispensing pharmacy by facsimile. The prescription transmitted via
				facsimile will be accepted as the original prescription for purposes of this
				section.
(d) Prescriptions
				transmitted by facsimile machine in accordance with subsections (b) and (c) of
				this section shall comply with the requirements set forth in subsection (b) of
				Section
				21a-243-15
				of the Regulations of Connecticut State Agencies.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Drug Prescriptions Transmitted by Facsimile Machines › Section 21a-243-15 - Schedule III, IV and V controlled substances

Current through July 10, 2024
(a)
				Prescriptions for Schedule III, IV and V controlled substances may be
				transmitted by a prescribing practitioner or his agent to a pharmacy by means
				of a facsimile machine.
(b) All
				prescriptions transmitted pursuant to subsection (a) of this section must
				comply with the following in addition to any other requirement of federal or
				state statute or regulation:
(1) The facsimile
				prescription shall clearly contain the name of the pharmacy to which the
				facsimile is being transmitted and the name of the facility from which it is
				transmitted if the prescription is written for an inpatient of a chronic or
				convalescent nursing home or a rest home with nursing supervision;
(2) The facsimile prescription shall clearly
				display a statement in substantially the following form: "This prescription is
				valid only if transmitted by means of a facsimile machine"; and
(3) The facsimile document may be maintained
				as the actual prescription only if the nature of the equipment and paper
				ensures that the prescription will remain non-fading and durable for the
				minimum amount of time required for the maintenance of prescription records
				under federal and state statute or regulation. If the document will not remain
				non-fading or durable, the prescription transmitted by facsimile machine shall
				be reduced to writing, photocopied or converted to an individual
				printout.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Drug Prescriptions Transmitted by Facsimile Machines › Section 21a-243-16 - Accuracy of prescription

Current through July 10, 2024
If a pharmacist questions the accuracy or authenticity of a
				  prescription transmitted by facsimile machine, he or she shall contact the
				  prescribing practitioner for verification before dispensing the
				  prescription.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Drug Prescriptions Transmitted by Facsimile Machines › Section 21a-243-17 - Relationship with prescribing practitioners and health care facilities

Current through July 10, 2024
(a) No pharmacist or pharmacy shall maintain
				direct telephone, facsimile machine or computer lines to any health care
				facility or prescribing practitioner's office.
(b) No pharmacist shall enter into any
				agreement with a prescribing practitioner or health care facility concerning
				the provision of facsimile machine services or equipment which adversely
				affects any person's freedom to choose the pharmacy at which a prescription
				will be filled.
Connecticut Administrative Code › Title 21a - Consumer Protection › 243 - Designation of Controlled Drugs › Drug Prescriptions Transmitted by Facsimile Machines › Section 21a-243-18 - Control of prescription forms

Current through July 10, 2024
It shall be the responsibility of the prescribing
				  practitioner to ensure that the prescription form that is used to transmit a
				  prescription by facsimile machine is either destroyed immediately or marked or
				  controlled in such a manner that prevents the use of such form to obtain
				  controlled substances other than as authorized by these
				  regulations.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-1 - Computer systems requirements

Current through July 10, 2024
(a) All
			 prescriptions for schedule II controlled substances, and original written and
			 oral prescriptions for schedule III, IV and V controlled substances shall be
			 received, executed and filed in accordance with sections
			 21a-249
			 and
			 21a-250
			 of the Connecticut General Statutes and all applicable federal laws and
			 regulations. In the case of original oral prescriptions for schedule III, IV
			 and V controlled substances, which shall be received by a pharmacist, an
			 individual hard copy printout of the prescription containing all required
			 information may be used to satisfy the requirements of section
			 21a-249(d)
			 of the Connecticut General Statutes.
(b) In the case of refills of prescriptions
			 for schedule III, IV and V controlled substances, an automated data processing
			 system may be used for the storage and retrieval of refill information. Any
			 such computerized system shall provide on-line retrieval for a period of at
			 least six months from the date of the last recorded dispensing via visual
			 display device or hardcopy printout of original prescription order information
			 for all prescriptions including those prescription orders which are currently
			 authorized for refilling. This shall include but is not limited to data such
			 as:
(1) the original prescription
			 number;
(2) the date of issuance of
			 the original prescription order by the prescribing practitioner;
(3) the full name and complete address of the
			 patient;
(4) the full name, full
			 address, and Drug Enforcement Administration, United States Department of
			 Justice, or its successor agency registration number of the prescribing
			 practitioner;
(5) the name,
			 strength, dosage form, quantity of the controlled substance prescribed and
			 quantity dispensed if different from the quantity prescribed; and
(6) the total number of refills authorized by
			 the prescribing practitioner.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-2 - Refill history capability requirement

Current through July 10, 2024
Any computerized system must also provide on line retrieval via
				visual display device or hard copy printout of the current refill history for
				Schedule III, IV, or V controlled substance prescription orders which are
				currently authorized for refilling. This refill history shall include but is
				not limited to:
(a) the full name and
			 address of patient;
(b) the full
			 name and complete address of the prescribing practitioner;
(c) the name, strength and dosage form of the
			 controlled substance;
(d) the date
			 of refill;
(e) the quantity
			 dispensed;
(f) the date on which
			 the prescription was first dispensed;
(g) the original number assigned to said
			 prescription;
(h) the name or
			 initials of the dispensing pharmacist for each refill; and
(i) the total number of refills dispensed to
			 date for that prescription order.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-3 - Documentation of data requirement

Current through July 10, 2024
Documentation of the fact that the refill information entered
				into the computer each time a pharmacist refills an original prescription order
				for a Schedule III, IV or V controlled substance is correct must be provided by
				the individual pharmacist who makes use of such a system. In order to
				accomplish this documentation, a pharmacy using such a computerized system must
				provide either:
(1) a separate
			 hard-copy printout of controlled substance prescription order refill data for
			 each day. This hard copy printout shall include the refill data mentioned in
			 section
			 21a-244-2
			 of the Regulations of Connecticut State Agencies except that it need not
			 contain the address of the patient or the address of the prescribing
			 practitioner. Each prescription on said printout shall be reviewed by each
			 individual pharmacist who refilled such a prescription order. The individual
			 pharmacist must verify that the data indicated is correct and then sign this
			 document in the same manner as he would sign a check or legal document. This
			 document shall be maintained in a separate file at that pharmacy for a period
			 of three years from the dispensing date. This printout of the controlled
			 substance prescription order refill data must be provided by each pharmacy
			 using such a computerized system within 72 hours of the date on which the
			 refill was dispensed and must be verified and signed by each pharmacist who
			 effected such dispensing as soon as possible after receipt. In no case shall
			 the printout be verified and signed later than the pharmacist's first work
			 period following receipt of the document; or
(2) In lieu of producing a hardcopy printout
			 of daily refill information signed by each dispensing pharmacist, the pharmacy
			 shall maintain a bound log book or separate file which each pharmacist involved
			 in such dispensing shall sign in the same manner as he would sign a check or
			 legal document. The signature of the dispensing pharmacist shall indicate that
			 he has reviewed the refill information entered into the computer, which is
			 attributed to him, for each date of dispensing and that it is correct as shown.
			 Whenever possible, this log book or separate file shall be signed by each
			 pharmacist on the date of dispensing but in no case shall it be signed later
			 than the pharmacist's first work period in that pharmacy after such
			 date.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-4 - Information available to commissioner upon request

Current through July 10, 2024
Any computerized system shall have the capability of producing
				a printout of any refill data which the utilizing pharmacy is responsible for
				maintaining under Chapter 420b of the general statutes and the regulations
				promulgated thereunder. This shall include the capability to produce a refill
				by refill audit trail for any specified strength and dosage form of any
				controlled substance by either brand or generic name or both. Said printout
				shall be produced within 48 hours and shall indicate the following:
(a) the name of the prescribing
			 practitioner;
(b) the name and
			 address of the patient;
(c) the
			 name, dosage form, strength, and quantity of the drug dispensed on each
			 refill;
(d) the name or initials of
			 the dispensing pharmacist and the date of dispensing for each refill;
			 and
(f) the number of the original
			 prescription order.
Any pharmacy utilizing a computerized system and authorized to
				maintain records at a central record-keeping location, must be capable of
				obtaining the requested printout within 48 hours.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-5 - Auxiliary system provision

Current through July 10, 2024
In the event that a pharmacy which employs such a computerized
				system experiences system down-time, the pharmacy must have an auxiliary
				procedure which will be used for documentation of refills of Schedule III, IV
				or V controlled substance prescription orders. This auxiliary procedure must
				insure that refills are authorized by the original prescription order and that
				all of the appropriate data is retained for on-line data entry as soon as the
				computer system is available for use again. All prescriptions refilled during
				the down-time shall be confirmed as being authorized upon resumption of on-line
				service.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-6 - When handwritten system is allowed

Current through July 10, 2024
If an automated data processing system is used for the storage
				and retrieval or refill information for prescription orders as authorized by
				Section
				21a-244
				of the general statutes, and the regulations promulgated thereunder, the
				pharmacy may use a traditional, handwritten system only to satisfy the
				requirement of Section
				21a-244-5
				of the regulations of State agencies.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-7 - Notice to commissioner upon commencement of use

Current through July 10, 2024
Any pharmacy instituting an automated data processing system
				for the storage and retrieval of refill information for prescription orders as
				authorized by Section
				21a-244
				of the general statutes and the regulations promulgated thereunder shall notify
				in writing the Drug Control Division of the Department of Consumer Protection
				at least 30 days prior to the commencement of usage of said
				system.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-9 - Requirement of safeguards

Current through July 10, 2024
If an automated data processing system is used for the storage
				and retrieval of refill information for prescription orders as authorized by
				Section
				21a-244
				of the general statutes and the regulations promulgated thereunder, it
				shall:
(a) guarantee the
			 confidentiality of the information contained in the data bank; and
(b) be capable of providing safeguards
			 against erasures and unauthorized changes in data after the information has
			 been entered and verified by the pharmacist.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-10 - Reconstruction of data in case of accident

Current through July 10, 2024
If an automated data processing system is used for the storage
				and retrieval of refill information for prescription orders as authorized by
				Section
				21a-244
				of the general statutes and the regulations promulgated thereunder, said
				automated data processing system shall be capable of being reconstructed in the
				event of a computer malfunction or accident resulting in the destruction of the
				data bank.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244 - Storage and Retrieval of Prescription Information for Controlled Substances › Section 21a-244-11 - Discontinuance of data processing system

Current through July 10, 2024
In the event that a pharmacy using an electronic data
				processing system for storage and retrieval of information goes out of
				business, sells out to another pharmacy that does not wish to use such a
				system, or discontinues use of the computer system, the pharmacy shall:
(a) notify the Drug Control Division of the
			 Department of Consumer Protection in writing at least 30 days prior to
			 discontinuance of said system;
(b)
			 provide an up-date hard-copy printout of all prescriptions stored in the
			 automated system for the three years immediately preceding as part of the final
			 records of that pharmacy prior to a change over to a manual system;
			 and
(c) make provision for these
			 records to be available to any nearby pharmacy in the event that the pharmacy
			 closes, as provided in Section
			 20-615
			 of the general statutes.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244a - Electronic Drug Records Maintained by Hospital and Medical Practitioners › Section 21a-244a-1

Current through July 10, 2024
As used in section
				21a-244a-2
				to section
				21a-244a-4,
				inclusive, of the Regulations of Connecticut State Agencies:
(1) "Drug record" means "drug record" as
			 defined in section
			 21a-244a
			 of the Connecticut General Statutes;
(2) "Hospital" means "hospital" as defined in
			 section
			 19a-490
			 of the Connecticut General Statutes; and
(3) "Licensed practitioner" means "licensed
			 practitioner" as defined in section
			 21a-244a
			 of the Connecticut General Statutes.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244a - Electronic Drug Records Maintained by Hospital and Medical Practitioners › Section 21a-244a-2

Current through July 10, 2024
Hospitals and licensed practitioners may create and maintain
				drug records using an electronic data processing system, provided they comply
				with the requirements of sections
				21a-244a-3
				and
				21a-244a-4 of
				the Regulations of Connecticut State Agencies.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244a - Electronic Drug Records Maintained by Hospital and Medical Practitioners › Section 21a-244a-3

Current through July 10, 2024
Hospitals and licensed practitioners shall establish and comply
				with a policy in creating and maintaining electronic drug records. This policy
				shall be maintained electronically or in writing, shall be dated and shall
				accurately reflect the manner in which electronic drug records are currently
				created and maintained. This policy shall be readily available for inspection
				by the Department of Consumer Protection for a period of three years from its
				last effective date.
Connecticut Administrative Code › Title 21a - Consumer Protection › 244a - Electronic Drug Records Maintained by Hospital and Medical Practitioners › Section 21a-244a-4

Current through July 10, 2024
Any hospital or licensed practitioner, in establishing the
				policy required by section
				21a-244a-3
				of the Regulations of Connecticut State Agencies, shall include:
(1) a description of the electronic data
			 processing system being used to create and maintain records. This description
			 shall include at least the following information:
(A) the specific types of drug records being
			 maintained electronically on the system; and
(B) the patient populations and physical
			 locations for which the electronic drug record system is being
			 utilized;
Connecticut Administrative Code › Title 21a - Consumer Protection › 254 - Record Keeping for Controlled Drugs › Section 21a-254-1 - Records

Current through July 10, 2024
(a) In general, special and long-term
			 hospitals there shall be a separate proof of use sheet as required in
			 subsection (e) of section
			 21a-254
			 of the general statutes for controlled drugs which are not dispensed or
			 administered directly to patients from the hospital's pharmacy but are
			 administered or dispensed from each floor stock. Such proof of use record shall
			 show the date of administering or dispensing, the name of the person to whom or
			 for whose use the drug is administered or dispensed, the kind and quantity of
			 drug, the time of administering or dispensing, the prescribing physician and
			 the nurse administering or dispensing the drug.
(b) In general, special and long-term
			 hospitals where controlled drugs are dispensed or administered directly to
			 patients from the hospital's pharmacy in quantities not exceeding four days'
			 supply, the hospital may use a duplicate copy of the patient's medication
			 record to record the drug administration or dispensing in lieu of a separate
			 proof of use record as required by said subsection (e) of section
			 21a-254.
			 Such records and any unused drugs or portions thereof shall be promptly
			 returned to the hospital pharmacy when no longer required by the
			 patient.
Connecticut Administrative Code › Title 21a - Consumer Protection › 254 - Record Keeping for Controlled Drugs › Electronic Prescription Drug Monitoring Program › Section 21a-254-2 - Definitions

Current through July 10, 2024
As used in sections 21a-254-2 to
				  21a-254-7,
				  inclusive, of the Regulations of Connecticut State Agencies:
(1) "Controlled substance" means "controlled
				substance" as defined in section
				21a-240
				of the Connecticut General Statutes;
(2) "Department" means the Department of
				Consumer Protection;
(3) "Pharmacy"
				means "pharmacy" as defined in section
				20-571
				of the Connecticut General Statutes, or a pharmacy located in a hospital, long
				term care facility or correctional facility; and
(4) "Practitioner" means "Prescribing
				practitioner" as defined in section
				20-571
				of the Connecticut General Statutes.
Connecticut Administrative Code › Title 21a - Consumer Protection › 254 - Record Keeping for Controlled Drugs › Electronic Prescription Drug Monitoring Program › Section 21a-254-3 - General requirements

Current through July 10, 2024
A pharmacy that dispenses schedule II, III, IV, and V
				  controlled substances shall transmit the prescription information for these
				  controlled substances to the department. A hospital pharmacy, long term care
				  facility pharmacy or correctional facility pharmacy shall transmit controlled
				  prescription information for outpatients only.
Connecticut Administrative Code › Title 21a - Consumer Protection › 254 - Record Keeping for Controlled Drugs › Electronic Prescription Drug Monitoring Program › Section 21a-254-4 - Reporting

Current through July 10, 2024
(a) A pharmacy that maintains prescription
				information electronically, and that dispenses a schedule II, III, IV, or V
				controlled substance to a person who is not an inpatient of a hospital,
				correctional institution or nursing facility, shall transmit electronically to
				the Drug Control Division of the department the information set forth in the
				most recent edition of the Electronic Reporting Standard for Prescription
				Monitoring Programs established by the American Society for Automation in
				Pharmacy. A pharmacy shall transmit to the department the fields listed in said
				reporting standard, including, but not limited to, the following:
(1) Drug Enforcement Administration Pharmacy
				number;
(2) Birth date;
(3) Sex code;
(4) Date prescription filled;
(5) Prescription number;
(6) New-refill code;
(7) Quantity;
(8) Days supply;
(9) National Drug Code number;
(10) Drug Enforcement Administration
				Prescriber identification number;
(11) Date prescription written;
(12) Number of refills authorized;
(13) Prescription origin code;
(14) Patient last name;
(15) Patient first name;
(16) Patient street address;
(17) State;
(18) Payment code for either cash or
				third-party provider; and
(19) Drug
				name.
Connecticut Administrative Code › Title 21a - Consumer Protection › 254 - Record Keeping for Controlled Drugs › Electronic Prescription Drug Monitoring Program › Section 21a-254-5 - Evaluation

Current through July 10, 2024
Agents of the Drug Control Division of the department, and
				  any department employee authorized to work with the Drug Control Division,
				  shall evaluate the controlled substance prescription information received from
				  pharmacies. The department shall evaluate the prescription information for the
				  purposes of preventing controlled substance diversion, public health
				  initiatives, and statistical reporting.
Connecticut Administrative Code › Title 21a - Consumer Protection › 254 - Record Keeping for Controlled Drugs › Electronic Prescription Drug Monitoring Program › Section 21a-254-6 - Management of information

Current through July 10, 2024
The department may provide prescription information obtained
				  from pharmacies to:
(a) Other
				regulatory, investigative or law enforcement agencies for disciplinary, civil,
				or criminal purposes;
(b)
				Practitioners, for the purpose of education in lieu of disciplinary, civil or
				criminal action;
(c) Practitioners
				and pharmacists, for the purposes of patient care, drug therapy management and
				monitoring of controlled substances obtained by the patient; and
(d) Public or private entities, for
				statistical, research, or educational purposes, provided that the privacy of
				patients and confidentiality of patient information is not
				compromised.